(Q43215440)

16 November 2017

title

Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections (English)

1 reference

16 November 2017

1 reference

Elizabeth D Hermsen

1

1 reference

16 November 2017

Monica Hanson

2

1 reference

16 November 2017

Jayashri Sankaranarayanan

3

1 reference

16 November 2017

Julie A Stoner

4

1 reference

16 November 2017

Marius C Florescu

5

1 reference

16 November 2017

Mark E Rupp

6

1 reference

16 November 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

Expert Opinion on Drug Safety

16 November 2017

published in

1 reference

16 November 2017

volume

9

1 reference

16 November 2017

issue

1

1 reference

16 November 2017

page(s)

9-14

1 reference

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740330903413514

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903413514

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903413514

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903413514

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903413514

Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903413514

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903413514

The role of vancomycin in the treatment paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903413514

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903413514

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903413514

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903413514

10.1517/14740330903413514

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference